Arbutus Biopharma Corp (ABUS)

2.68 -0.02  -0.74% NASDAQ Jul 28, 09:08 USD
View Full Chart
Price Chart
View All ABUS News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
08/06/2021 08:45 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:45 EST Earnings Calls Q1 2021 Earnings Call
03/04/2021 Earnings Results Q4 2020 Earnings Results
03/04/2021 08:45 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
11/05/2020 08:45 EST Earnings Calls Q3 2020 Earnings Call
08/07/2020 08:45 EST Earnings Calls Q2 2020 Earnings Call
08/07/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.
  • URL: http://www.arbutusbio.com
  • Investor Relations URL: https://investor.arbutusbio.com
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.